U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C27H36N2O5
Molecular Weight 468.5851
Optical Activity ( + )
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of IVABRADINE

SMILES

COC1=C(OC)C=C2[C@@H](CN(C)CCCN3CCC4=CC(OC)=C(OC)C=C4CC3=O)CC2=C1

InChI

InChIKey=ACRHBAYQBXXRTO-OAQYLSRUSA-N
InChI=1S/C27H36N2O5/c1-28(17-21-11-20-14-25(33-4)26(34-5)16-22(20)21)8-6-9-29-10-7-18-12-23(31-2)24(32-3)13-19(18)15-27(29)30/h12-14,16,21H,6-11,15,17H2,1-5H3/t21-/m1/s1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
IVABRADINE
DASH   EMA EPAR   INN   MART.   MI   USAN   WHO-DD  
INN   USAN  
Official Name English
S-16257
Code English
Ivabradine [WHO-DD]
Common Name English
IVABRADINE [MI]
Common Name English
IVABRADINE [EMA EPAR]
Common Name English
IVABRADINE [MART.]
Common Name English
IVABRADINE [ORANGE BOOK]
Common Name English
3-(3-((((7S)-3,4-DIMETHOXYBICYCLO(4.2.0)OCTA-1,3,5-TRIEN-7-YL)METHYL)METHYLAMINO)PROPYL)-1,3,4,5-TETRAHYDRO-7,8-DIMETHOXY-2H-3-BENZAZEPIN-2-ONE
Systematic Name English
IVABRADINE [USAN]
Common Name English
ivabradine [INN]
Common Name English
Classification Tree Code System Code
WHO-ATC C07FX06
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
FDA ORPHAN DRUG 511915
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
NCI_THESAURUS C47793
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
WHO-ATC C07FX05
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
WHO-VATC QC01EB17
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
FDA ORPHAN DRUG 631818
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
WHO-ATC C01EB17
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
NDF-RT N0000191544
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
Code System Code Type Description
DAILYMED
3H48L0LPZQ
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
IUPHAR
2357
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
NCI_THESAURUS
C65995
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
CHEBI
85969
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
EPA CompTox
DTXSID2048240
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
ChEMBL
CHEMBL471737
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
SMS_ID
100000085462
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
PUBCHEM
132999
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
NDF-RT
N0000191546
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY Hyperpolarization-activated Cyclic Nucleotide-gated Channel Antagonists [MoA]
CAS
155974-00-8
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
DRUG BANK
DB09083
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
USAN
BC-97
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
CHEBI
85966
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
EVMPD
SUB08357MIG
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
INN
7523
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
MERCK INDEX
m6564
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY Merck Index
FDA UNII
3H48L0LPZQ
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
WIKIPEDIA
IVABRADINE
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
DRUG CENTRAL
3312
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY
RXCUI
1649480
Created by admin on Fri Dec 15 16:02:01 UTC 2023 , Edited by admin on Fri Dec 15 16:02:01 UTC 2023
PRIMARY RxNorm
ACTIVE MOIETY
Structure of IVABRADINE
METABOLITE ACTIVE (PARENT)
Structure of N-DEMETHYLIVABRADINE
SALT/SOLVATE (PARENT)
Structure of IVABRADINE HEMISULFATE
SALT/SOLVATE (PARENT)
Structure of IVABRADINE ADIPATE
SALT/SOLVATE (PARENT)
Structure of IVABRADINE HYDROBROMIDE
SALT/SOLVATE (PARENT)
Structure of IVABRADINE SULFATE
SALT/SOLVATE (PARENT)
Structure of IVABRADINE OXALATE
SALT/SOLVATE (PARENT)
Structure of IVABRADINE HYDROCHLORIDE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966